A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)
Supported projects > Other Supported Projects · 2017
Authors: Tuncay GÖKSEL
2017-2021, Other Supported Projects, R & D Project, Continues